Rebel Life Sciences is a PhD-led advanced R&D and strategic firm built for advanced technology development and deployment — with the rare distinction of having pioneered these platforms in the public and private sectors, having forged a standard where the margin for error is zero.
From microgravity research aboard the ISS to new approach methodologies that are reshaping how scientific evidence is generated — Rebel deploys these capabilities operationally, not theoretically. We develop these technologies in our own programs and deploy them for clients who need to move beyond conventional methods.
Thought leadership in microgravity enabled research, development and manufacturing including partnerships with the ISS National Lab, CASIS and other public and private entities in the US, EU and globally.
In silico modeling, organ-on-chip platforms, bioprinted constructs, digital twins and advanced AI-driven analytics — deployed as primary scientific tools. We help our clients identify, develop and deploy NAMs to compress timelines, reduce reliance on conventional methods and generate better, more accurate evidence to revolutionize traditional discovery and approval paradigms.
Layer-by-layer fabrication of biological structures for modeling, construct development and advanced technology applications. We apply our own pioneering program strategies to bring depth and rigor to client programs.
Creating strategies and programs around the most advanced modeling and simulation techniques to create 'predict-learn-confirm' human relevant models to inform discovery and decision making.
OoC platforms and MPS that recreate the dynamic environment of human systems with translational fidelity that conventional models can't achieve. Deployed in our advanced research platform, we help our clients create large, human-relevant data sets that drive the accuracy and precision needed for in silico discovery engines and regulatory policy transformations.
AI driven scientific tools — applied as business relevant opportunities, not black boxes. Our approach combines technical rigor, with real world industry experience to generate actionable strategies that will hold up to scrutiny.
We design and execute research programs built to generate evidence that moves programs, attracts funding, and withstands the highest scientific scrutiny. Strategy built into every study from day one.
We architect the development strategy and deliver the evidence packages that advance products. Scientific depth combined with the operational speed to get there before the competition.
Technical consulting, expert advisory, scientific writing, and litigation support — delivered by experts who have occupied senior positions at the world's leading life science organizations. Not advisors. Operators who have been exactly where your program is.
Rebel's active work in the advanced tech and space sectors are not a positioning statement. We operate where biology intersects with the extreme demands of advanced disciplines and technologies.
When the margin for error is zero, and physical or terrestrial experimentation is profoundly constrained, we build the strategy, teams, methodologies, tools and bring the scientific rigor that make the impossible, routine.
A legacy of thought leadership among public and private agencies engaged in LEO based technologies and platforms.
Innovations developed at the frontier that we use as a foundation for both space based and terrestrial applications.
Direct agency relationships in the US, EU and globally, in both the public and private sectors — giving unprecedented access to funding mechanisms, partnerships, and consortia.
We use microgravity as an active scientific tool — not a destination. The biological behaviors, bioprinting capabilities, and physiological insights from space inform everything we build on Earth.
Scientific excellence without strategic execution leaves value on the table. Our strategy practice brings the same PhD-level rigor and senior industry experience to the business, regulatory, and organizational decisions that determine whether programs succeed.
Business development, partnership strategy, and government contracting — including federal agency relationships. We help organizations build the relationships and positioning that opens doors others don't know exist.
From non-dilutive funding strategies and grant execution to VC positioning, consortia building, and commercial launch — We understand how capital moves in life sciences and how to position programs for it.
Regulatory strategy and quality systems designed from day one around your development pathway and target markets. We integrate regulatory thinking into your program from the earliest decisions — so every study, every process, and every dataset is already aligned to your approval strategy.
Pipeline prioritization, resource allocation, lifecycle management, and operational excellence — the discipline that keeps high-performing organizations performing. We build the governance structures and decision frameworks that ensure your resources are always deployed against your highest-value opportunities.
Rebel Life Sciences was built for organizations that need scientific depth, not scientific advice. We are a PhD-led R&D and scientific strategy firm — not a consultancy that observes life sciences from the outside. Our team has led programs, built IP portfolios, managed regulatory interactions, and executed across the full development lifecycle at major biotech, medtech, and pharmaceutical organizations.
We don't accept the conventional ceiling of what science can accomplish. Every program we touch is approached with the rigor we've developed in environments where the margin for error is zero.
Every Rebel expert has been in the room where consequential decisions get made — not observing from the outside. That is a categorically different level of expertise, and it shows in the work.
Our active work in the space and advanced technology sectors is not peripheral to our business — it is the proving ground for the methodologies, standards and technologies we bring to every program.
When your organization needs an external scientific and strategic perspective, we deliver genuine independence — objective, defensible, and free from the conflicts that compromise most experts.
We are not looking for credentials. We are looking for people who have done the work — who have led programs, solved problems others walked away from, and who hold themselves to a standard that most organizations don't demand. If that is you, we want to hear from you.
Reach OutTell us about your program, your challenge, or your organization. We will tell you directly whether and how we can help.
Rebel is selectively building relationships with investors who share our conviction that the most significant returns in life sciences come from refusing to accept conventional limits.